ARCHIVES

Senate Debates $1.1 Trillion “Cromnibus” Bill That Includes a $150 Million Increase for NIH

This article is from The Cancer Letter archive.

Vol. 40 No. 46 | December 12, 2014

Download PDF Visit The Full Archive

Related Articles

FDA Approves Abraxane For Second-Line Treatment Of Metastatic Breast Cancer

January 28, 2005

Draft of National Action Plan On Breast Cancer Targets Health Care, Research, Policy

March 23, 1994

Prostate Ultrasound Markers Concepts Approved by BSC

October 3, 1986

In Brief: NCI Awards $1.2 Million To Mt. Sinai To Establish Specialized Cancer Center

July 26, 1974

Single-Letter Mutation Found Responsible For Waldenstrom’s

December 30, 2011

FDA Approves Rituxan For CLL

February 19, 2010